03.09.2014 Views

Efficacy of FX Minirail Balloon in Bifurcation Lesions - summitMD.com

Efficacy of FX Minirail Balloon in Bifurcation Lesions - summitMD.com

Efficacy of FX Minirail Balloon in Bifurcation Lesions - summitMD.com

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

<strong>Efficacy</strong> <strong>of</strong> <strong>FX</strong> <strong>M<strong>in</strong>irail</strong> <strong>Balloon</strong><br />

<strong>in</strong> <strong>Bifurcation</strong> <strong>Lesions</strong><br />

Junbo Ge, MD, FACC, FESC<br />

Pr<strong>of</strong>essor <strong>of</strong> Medic<strong>in</strong>e/Cardiology<br />

Zhongshan Hospital, Fudan University<br />

Shanghai Institute <strong>of</strong> cardiovascular Diseases<br />

Shanghai, Ch<strong>in</strong>a


PCI <strong>in</strong> bifurcation lesions<br />

Until recently, PCI <strong>in</strong> bifurcation lesions had<br />

rema<strong>in</strong>ed technically challeng<strong>in</strong>g.<br />

Immediate and mid-term results us<strong>in</strong>g<br />

balloon angioplasty were poor:<br />

Low angiographic success rate (75-85%)<br />

High <strong>in</strong>cidence <strong>of</strong> <strong>com</strong>plication (8-22%)<br />

High restenosis rate (40-65%)


Cypher TM Compared with Bare Metal Stents<br />

Side-Branch<br />

ln-Lesion<br />

Restenosis<br />

Bare Metal Stent<br />

Yamashita<br />

Cypher TM<br />

Stent<br />

SIRIUS <strong>Bifurcation</strong>s


Cutt<strong>in</strong>g <strong>Balloon</strong>


QCA Analysis (Basel<strong>in</strong>e)<br />

(mm)<br />

3<br />

2.76<br />

2.66<br />

POBA<br />

CB<br />

2<br />

0.93 0.95<br />

1<br />

0<br />

Reference Diameter<br />

MLD


QCA Analysis (Basel<strong>in</strong>e)<br />

30<br />

20<br />

18.7<br />

20.9<br />

10<br />

0<br />

Lesion Length


QCA Analysis (Post Procedure)<br />

2.5<br />

2.24<br />

*<br />

2.07<br />

POBA<br />

CB<br />

2<br />

1.5<br />

1.28<br />

*<br />

1.12<br />

1<br />

0.5<br />

0<br />

MLD<br />

Acute Ga<strong>in</strong><br />

* p


QCA Analysis (Follow-up)<br />

1.5<br />

1.22<br />

*<br />

1.43<br />

POBA<br />

CB<br />

1<br />

0.5<br />

0.9<br />

*<br />

0.67 0.67<br />

0.55<br />

• Follow-up<br />

period:<br />

5.7±2.3 mo.<br />

• Follow-up<br />

Rate: 63.9%<br />

0<br />

MLD<br />

Late Loss<br />

Loss Index<br />

* p


Restenosis & TLR<br />

60<br />

58<br />

*<br />

47<br />

POBA<br />

CB<br />

39<br />

40<br />

*<br />

21<br />

20<br />

0<br />

Restenosis<br />

TLR<br />

* p


Cutt<strong>in</strong>g balloon angioplasty<br />

<strong>in</strong> proximal LAD bifurcation lesion<br />

Case # 1<br />

• Male, 58 yr<br />

• Anterior MI 1 month ago<br />

• Pre-<strong>in</strong>tervention<br />

angiogram


Cutt<strong>in</strong>g balloon angioplasty<br />

<strong>in</strong> proximal LAD bifurcation lesion<br />

Case # 1<br />

• Proximal LAD<br />

• C.B 3.5mm * 8atm


Cutt<strong>in</strong>g balloon angioplasty<br />

<strong>in</strong> proximal LAD bifurcation lesion<br />

Case # 1<br />

• F<strong>in</strong>al result


Cutt<strong>in</strong>g balloon angioplasty<br />

<strong>in</strong> proximal LAD bifurcation lesion<br />

Case # 1


Cutt<strong>in</strong>g balloon angioplasty prior to<br />

stent<strong>in</strong>g <strong>in</strong> bifurcation lesion<br />

Case # 2<br />

• Male, 52 yr<br />

• Exertional ang<strong>in</strong>a<br />

• Pre-<strong>in</strong>tervention<br />

angiogram


Cutt<strong>in</strong>g balloon angioplasty prior to<br />

stent<strong>in</strong>g <strong>in</strong> bifurcation lesion<br />

Case # 2<br />

• Ostial Diag<br />

• C.B 2.75mm * 10atm<br />

• LAD<br />

• C.B 2.75mm * 10atm


Cutt<strong>in</strong>g balloon angioplasty prior to<br />

stent<strong>in</strong>g <strong>in</strong> bifurcation lesion<br />

Case # 2<br />

• LAD stent<strong>in</strong>g<br />

• 3.5mm*18mm stent


Cutt<strong>in</strong>g balloon angioplasty prior to<br />

stent<strong>in</strong>g <strong>in</strong> bifurcation lesion<br />

Case # 2<br />

• F<strong>in</strong>al result


Cutt<strong>in</strong>g balloon angioplasty prior to<br />

stent<strong>in</strong>g <strong>in</strong> bifurcation lesion<br />

Case # 2


<strong>FX</strong> m<strong>in</strong>iRAIL RX PTCA Catheter


<strong>FX</strong> m<strong>in</strong>iRAIL Angioplasty<br />

• <strong>FX</strong> m<strong>in</strong>iRAIL<br />

Catheter: A well-rounded<br />

approach to a cutt<strong>in</strong>g-<br />

edge solution.<br />

• Concentrated stress<br />

creates expansion planes<br />

at low pressures for<br />

controlled dilatation.<br />

• Stress concentration<br />

• Stability<br />

• Pushability


<strong>FX</strong> m<strong>in</strong>iRAIL Angioplasty


<strong>FX</strong> m<strong>in</strong>iRAIL angioplasty <strong>in</strong><br />

proximal LAD bifurcation lesion<br />

Case # 1


<strong>FX</strong> m<strong>in</strong>iRAIL angioplasty <strong>in</strong><br />

proximal LAD bifurcation lesion<br />

Case # 1


<strong>FX</strong> m<strong>in</strong>iRAIL angioplasty <strong>in</strong><br />

proximal LAD bifurcation lesion<br />

Case # 1


m<strong>in</strong>iRAIL angioplasty <strong>in</strong> a<br />

<strong>FX</strong> m<strong>in</strong>iRAIL angioplasty <strong>in</strong> a<br />

diffuse atherosclerotic lesion<br />

Case # 2


m<strong>in</strong>iRAIL angioplasty <strong>in</strong> a<br />

<strong>FX</strong> m<strong>in</strong>iRAIL angioplasty <strong>in</strong> a<br />

diffuse atherosclerotic lesion<br />

Case # 2


m<strong>in</strong>iRAIL angioplasty <strong>in</strong> a<br />

<strong>FX</strong> m<strong>in</strong>iRAIL angioplasty <strong>in</strong> a<br />

diffuse atherosclerotic lesion<br />

Case # 2


<strong>FX</strong> m<strong>in</strong>iRAIL angioplasty <strong>in</strong><br />

Left Ma<strong>in</strong> Lesion<br />

Case # 3


<strong>FX</strong> m<strong>in</strong>iRAIL Angioplasty <strong>in</strong><br />

Left Ma<strong>in</strong> Lesion<br />

Case # 3


Conclusions<br />

• <strong>FX</strong> m<strong>in</strong>irail balloon is effective <strong>in</strong><br />

treatment <strong>of</strong> bifurcation lesions which<br />

causes less plaque shift<strong>in</strong>g.<br />

• In <strong>com</strong>parison to cutt<strong>in</strong>g balloon, <strong>FX</strong><br />

m<strong>in</strong>irail balloon achieves equally results <strong>in</strong><br />

bifurcation lesions.<br />

• Further studies needed <strong>in</strong> the treatment <strong>of</strong><br />

bifurcation lesions to prove the longterm<br />

benefit even <strong>in</strong> the DES era.

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!